Walleye Trading LLC Amylyx Pharmaceuticals, Inc. Call Options Transaction History

Walleye Trading LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	SELL	$2.71 - $19.57 $17,344 - $125,248	-6,400 Reduced 22.15%	22,500 $63,000
Q4 2023 Feb 14, 2024	SELL	$12.07 - $18.46 $144,840 - $221,520	-12,000 Reduced 29.34%	28,900 $425,000
Q3 2023 Nov 14, 2023	BUY	$18.08 - $23.45 $549,632 - $712,880	30,400 Added 289.52%	40,900 $748,000
Q2 2023 Aug 14, 2023	BUY	$20.98 - $31.42 $52,450 - $78,550	2,500 Added 31.25%	10,500 $226,000
Q1 2023 May 15, 2023	BUY	$27.71 - $40.93 $41,565 - $61,395	1,500 Added 23.08%	8,000 $234,000
Q4 2022 Feb 14, 2023	BUY	$29.75 - $39.26 $193,375 - $255,190	6,500 New	6,500 $240,000
Q2 2022 Aug 08, 2022	BUY	$6.85 - $19.93 $68,500 - $199,300	10,000 New	10,000 $193,000

139

46.5M

226K

909K

Ticker AMLX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,533,200
Market Cap $290M
Description
Amylyx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing various therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases. The company's product pipeline includes AMX0035, a dual UPR-Bax apoptosis inhibitor composed of sodium phenylbutyrate and taurursodiol for the treatment...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.